In-vitro fertilisation treatment: Factors affecting its results and outcome

References

• Akande V A, Fleming C F, Hunt L P, Keay S D, Jenkins J M. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Human Reproduction 2002; 17: 2003–2008
   PubMed Web of Science ®Google Scholar
• Balmaceda J P, Bernardini L, Ciuffardi I, Felix C, Ord T, Sueldo C E, et al. Oocyte donation in humans: a model to study the effect of age on embryo implantation rate. Human Reproduction 1994; 9: 2160–2163
   PubMed Web of Science ®Google Scholar
• Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilisation. Fertility and Sterility 2002; 77: 1148–1155
   PubMed Web of Science ®Google Scholar
• Collins J A, Bustillo M, Visscher R D, Lawrence L D. An estimate of the cost of in vitro fertilisation services in the United States in 1995. Fertility and Sterility 1995; 64: 538–545
   PubMed Web of Science ®Google Scholar
• Cramer D W, Liberman R F, Powers D, Hornstein M D, McShane P, Barbieri R L. Recent trends in assisted reproductive techniques and associated outcomes. Obstetrics and Gynecology 2000; 95: 61–66
   PubMed Web of Science ®Google Scholar
• Egbase P E, Al-Sharhan M, Grudzinskas J G. Influence of position and length of uterus on implantation and clinical pregnancy rates in IVF and embryo transfer treatment cycles. Human Reproduction 2000; 15: 1943–1946
   PubMed Web of Science ®Google Scholar
• Faber B M, Mayer J, Cox B, Jones D, Toner J P, Oehninger S, et al. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertility and Sterility 1998; 69: 826–830
   PubMed Web of Science ®Google Scholar
• Kovacs P, Matyas S Z, Boda K, Kaali S G. The effect of endometrial thickness on IVF/ICSI outcome. Human Reproduction 2003; 18: 2337–2341
   PubMed Web of Science ®Google Scholar
• Lidor A L, Cohen S B, Seidman D S, Mashiach S, Lipitz S, Goldenberg M. Preferred treatment of infertile women older than 37 years of age who demonstrate premature luteinisation in the first evaluation cycle. Fertility and Sterility 2000; 73: 321–324
   PubMed Web of Science ®Google Scholar
• Olivennes F, Righini C, Fanchin R, Torrisi C, Hazout A, Glissant M, et al. A protocol using a low dose of gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle stimulating hormone concentrations on day 3. Human Reproduction 1996; 11: 1169–1172
   PubMed Web of Science ®Google Scholar
• Palermo G, Joris H, Devroey P, Van Steirteghem A C. Pregnancies after intracytoplasmic sperm injection of single spermatozoon into an oocyte. Lancet 1992; 340: 17–18
   PubMed Web of Science ®Google Scholar
• Rombauts L, Suikkari A M, MacLachlan V, Trounson A O, Healy D L. Recruitment of follicles by recombinant human follicle stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertility and Sterility 1998; 69: 665–669
   PubMed Web of Science ®Google Scholar
• Rubio C, Gil-Salom M, Simon C, Vidal F, Rodrigo L, Minguez Y, et al. Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome. Human Reproduction 2001; 16: 2084–2092
   PubMed Web of Science ®Google Scholar
• Schoolcraft W B, Surrey E S, Gadner D K. Embryo transfer: techniques and variables affecting success. Fertility and Sterility 2001; 76: 863–870
   PubMed Web of Science ®Google Scholar
• Simon C, Garcia Velasco J J, Valbuena D, Peinado J A, Moreno C, et al. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of follicle -stimulating hormone step-down regimen. Fertility and Sterility 1998; 70: 234–239
   PubMed Web of Science ®Google Scholar
• Society for Assisted Reproductive Technology (SART) American Society for Reproductive Medicine (ASRAM). Assisted reproductive technology in the United States: 1998 results generated from American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertility and Sterility 2002; 77: 18–31
   PubMed Web of Science ®Google Scholar
• Steptoe P C, Edward R G. Birth after reimplantation of a human embryo. Lancet 1978; 2: 366
   PubMed Web of Science ®Google Scholar
• Surrey E S, Schoolcraft W B. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertility and Sterility 2000; 73: 667–676
   PubMed Web of Science ®Google Scholar
• Surrey E S, Bower J, Hill D M, Ramsey J, Surrey M W. Clinical and endocrine effects of a microdose GnRH-agonist flare regimen administered to poor responders who are undergoing in vitro fertilisation. Fertility and Sterility 1998; 69: 419–424
   PubMed Web of Science ®Google Scholar
• Tan S L, Royston P, Campbell S, Jacobs H S, Betts J, Mason B, et al. Cumulative conception and livebirth rates after in vitro fertilisation. Lancet 1992; 339: 1390–1394
   PubMed Web of Science ®Google Scholar
• Templeton A, Morris J K, Parslow W. Factors affecting outcome of in-vitro fertilisation treatment. Lancet 1996; 348: 1402–1406
   PubMed Web of Science ®Google Scholar
• Yaron Y, Botchan A, Amit A, Kogosowski A, Yovel I, Lessing J B. Endometrial receptivity: the age-related decline in pregnancy rates and the effect of ovarian function. Fertility and Sterility 1993; 60: 314–318
   PubMed Web of Science ®Google Scholar
• Yu Ng E H, Tang O S, Ho P C. The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF program. Human Reproduction 2000; 15: 1937–1942
   PubMed Web of Science ®Google Scholar